Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Abbott Laboratories ABT

Healthcare  —  Medical Devices
101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
S&P 500 Member Dividend Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Abbott Laboratories (ABT) EV/EBITDA

As of 25 September 2026, Abbott Laboratories (ABT) trades at a EV/EBITDA of 18.8×. Over the past ten years it has ranged from 12.1× (September 2015) to 29.5× (August 2020); the current reading is higher than 35% of that period. That is above the Medical Devices industry median of 11.8× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 19.9× (1.60%)
FY2024 20.2× (1.05%)
FY2023 20.4× 19.53%
FY2022 17.1× (20.66%)
FY2021 21.5× (9.01%)
FY2020 23.7× 6.70%
FY2019 22.2× 8.38%
FY2018 20.5× (6.57%)
FY2017 21.9× 67.03%
FY2016 13.1× (14.99%)

Quarterly

Period EV/EBITDA Change
Jun 2026 17.1× (9.44%)
Mar 2026 18.9× (4.85%)
Dec 2025 19.9× (9.60%)
Sep 2025 22.0× (3.64%)
42 more quarters

Against its own ten years

Low 12.1× High 29.5×
Ten-year median 20.3×
Current reading's percentile 35

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 8.6×
GEHC GE HealthCare Technologies Inc. compare 11.9×
STE STERIS plc compare 13.4×
MDT Medtronic PLC compare 13.7×
BSX Boston Scientific Corporation compare 13.8×
SYK Stryker Corporation compare 17.2×
ABT Abbott Laboratories 18.8×
DXCM DexCom, Inc. compare 23.2×
EW Edwards Lifesciences Corporation compare 28.6×
Medical Devices industry median 11.8×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ABT